Abilify and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Mesalamine (mesalamine). Common drug interactions include suicidal ideation among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Mesalamine. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

69 people who take Abilify and Mesalamine together, and have interactions are studied.

Abilify and Mesalamine drug interactions.

What are the common drug interactions of Abilify and Mesalamine, by gender? *:

female:

  1. Suicidal ideation
  2. Abdominal pain
  3. Body temperature decreased
  4. Heart rate decreased
  5. Sedation
  6. Accident
  7. Affective disorder (mental disorder)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  10. Cellulitis (infection under the skin)

male:

  1. Abdominal discomfort
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Haematochezia (passage of stools containing blood)
  5. Left ventricular failure (left ventricle fails to contract forcefully)
  6. Ligament rupture (tear in ligament)
  7. Lower limb fracture
  8. Nephrolithiasis (calculi in the kidneys)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Abilify and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Road traffic accident

10-19:

  1. Haematochezia (passage of stools containing blood)
  2. Abdominal discomfort
  3. Fall
  4. Infusion related reaction
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

  1. Left ventricular failure (left ventricle fails to contract forcefully)
  2. Decreased appetite
  3. Frequent bowel movements
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Muscle twitching
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Proctalgia (pain in the rectum)
  9. Rectal haemorrhage (bleeding from anus)
  10. Testicular pain (pain in testes)

30-39:

  1. Abdominal pain
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Frequent bowel movements
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Rash
  6. Respiratory disorder (respiratory disease)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Ankle fracture
  9. Anxiety
  10. Bone density decreased

40-49:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Nausea (feeling of having an urge to vomit)
  3. Pain
  4. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  5. Poisoning
  6. Poor quality sleep
  7. Social avoidant behaviour (avoiding social connection a personality disorder)
  8. Stress
  9. Suicide attempt
  10. Synovial cyst (cyst of joint filled with synovial fluid)

50-59:

  1. Urinary tract infection
  2. Blood pressure fluctuation
  3. Heart rate irregular
  4. Arthralgia (joint pain)
  5. Blood pressure increased
  6. Body temperature decreased
  7. Heart rate decreased
  8. Pneumonia
  9. Frequent bowel movements
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Sedation
  2. Influenza
  3. Flatulence (flatus expelled through the anus)
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Influenza like illness
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Pyrexia (fever)
  8. Incision site infection (infection at incision site)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Suicidal ideation

What are the existing conditions these people have? *

  1. Inflammation: 14 people, 20.29%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 18.84%
  3. Urinary Tract Infection: 10 people, 14.49%
  4. Pain: 7 people, 10.14%
  5. Sleep Apnea Syndrome: 6 people, 8.70%
  6. Nausea (feeling of having an urge to vomit): 5 people, 7.25%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 5.80%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 5.80%
  9. Drowsiness: 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and mesalamine (the active ingredients of Abilify and Mesalamine, respectively), and Abilify and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: